EGFR and cancer: This effect was evaluated in HT-29 colorectal cancer cells, this functionalization increases the endocytic capacity and thus the degradation of the EGFR by the lysosome, and this degradation becomes relevant in cancer therapy as it inhibits cell proliferation and induces apoptosis in HT-29 cancer cells [49].